Medicover AB (publ) is a Sweden-based healthcare and diagnostic services provider operating a network of medical centers, hospitals, clinics and laboratories across multiple geographies. The company offers a wide range of preventive and curative healthcare services, including general practice, specialist consultations, inpatient and outpatient care, surgical procedures and rehabilitation. Its diagnostic arm provides clinical chemistry, molecular diagnostics, histopathology and advanced imaging services supported by a network of accredited laboratories.
In addition to core healthcare and laboratory services, Medicover offers dedicated fertility and maternal care solutions, encompassing assisted reproductive technologies, obstetrics, gynaecology and prenatal diagnostics. The group has also developed telemedicine platforms and digital health applications to enhance patient engagement, remote monitoring and care coordination, reflecting its emphasis on integrated and patient-centric healthcare delivery.
Founded in 1995 and headquartered in Stockholm, Medicover has grown through organic expansion and strategic acquisitions, extending its presence to countries such as Germany, Poland, Romania, Turkey, Ukraine and India. The company continues to focus on creating synergies between diagnostics and clinical services, leveraging technology and standardized processes to drive operational efficiencies and improve patient outcomes.
Medicover’s governance structure comprises an independent board of directors and a management team with expertise in healthcare, diagnostics and corporate strategy. The company adheres to international quality and regulatory standards, demonstrating a commitment to clinical excellence, patient safety and sustainable growth.
AI Generated. May Contain Errors.
